Description
Indication & Scope
OuHuaYaZhouKang® Metronidazole and Fenbufen Capsules treats gingivitis and periodontitis; provide auxiliary relief for oral inflammation and glossitis caused by anaerobic bacterial infection.
- Mechanism: Metronidazole exerts bactericidal activity against oral anaerobes by disrupting bacterial DNA synthesis. Fenbufen is non-steroidal anti-inflammatory drug that inhibits prostaglandin production to relieve oral inflammatory pain and swelling. Two ingredients combine antibacterial and analgesic anti-inflammatory effects for oral infectious lesions.
- Drug class: Compound preparation of anti-anaerobic antibiotic and nonsteroidal anti-inflammatory analgesic.
- Clinical use: Symptomatic and etiological treatment of anaerobic bacterial oral soft tissue inflammation.
| Generic Name | Metronidazole and Fenbufen Capsules |
| Brand Name | OuHuaYaZhouKang® |
| Ingredient | Metronidazole and Fenbufen |
| Dosage Form | Capsules |
| Package | (Metronidazole 100mg + Fenbufen 75mg) *10 capsules/box;
(Metronidazole 100mg + Fenbufen 75mg) *18 capsules/box; (Metronidazole 100mg + Fenbufen 75mg) *20 capsules/box; (Metronidazole 100mg + Fenbufen 75mg) *30 capsules/box |
| Conditions Treated | Gingival inflammation, periodontal abscess, oral mucosal inflammation and glossitis associated with anaerobic infection |
| Taboos | Hypersensitivity to imidazole drugs or NSAIDs; asthma triggered by aspirin; active central nervous system diseases; blood disorders; active peptic ulcer; severe liver and renal damage; pregnant, lactating women and all children |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Light-proof, hermetically sealed storage |
| Manufacturer | Guangdong Huanan Pharmaceutical Group Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H44024371 |
| Approval Date | Dec 20, 2024 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: 1 capsule per oral administration, three times daily after meals.
Time: Take after meals to minimize gastric mucosal irritation caused by fenbufen.
Instructions for use: Complete full treatment course as dentists prescribe; alcoholic drinks are strictly forbidden during medication and within 7 days after withdrawal due to disulfiram-like reaction. Discontinue administration and seek medical help when numbness, convulsion or severe stomach pain occurs.
Interaction: Concomitant alcohol intake induces flushing, tachycardia, vomiting and hypotension. Combined anticoagulants such as warfarin increase bleeding tendency. Phenytoin and cimetidine alter hepatic metabolism of metronidazole to change blood drug concentration.
Side effects: Gastrointestinal upset including stomach burning, nausea and diarrhea; central nervous symptoms like headache, dizziness and peripheral nerve numbness. Rare leukopenia, skin allergic rash, severe convulsion and epileptic attack under excessive dosage.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What oral infectious conditions are targeted by Metronidazole and Fenbufen Capsules?
It treats anaerobic bacteria-induced gingivitis, periodontitis, oral mucositis and glossitis.
Which population categories have absolute contraindications to Metronidazole and Fenbufen Capsules?
Pregnant and breastfeeding individuals, children, ulcer patients and those with NSAID-induced asthma cannot take the drug.
What nervous system abnormal symptoms signal immediate drug discontinuation when using Metronidazole and Fenbufen Capsules?
Persistent limb numbness, frequent dizziness and convulsive episodes require prompt cessation of administration.
What core dual therapeutic functions does Metronidazole and Fenbufen Capsules provide?
Metronidazole eliminates oral anaerobic pathogens while fenbufen relieves inflammatory pain and tissue swelling.
OuHuaYaZhouKang® | Metronidazole and Fenbufen Capsules | Gingivitis/Periodontitis/Pericoronitis | DengYueRX
INN: Metronidazole and Fenbufen Capsules
Indications: Gingivitis, periodontitis, and pericoronitis
Dosage Form: Capsules
Strength: (Metronidazole 100mg + Fenbufen 75mg) / capsule
$2.34 Original price was: $2.34.$1.99Current price is: $1.99.